Until now, there has been a dearth of systematic and thorough research into the bioinformatics analysis of TXLNA about expression difference in brain gliomas, their clinical importance, and their mechanism of action, despite PCR analysis of TXLNA genes in glioma patients having been conducted. The gene discussed is TXLNA; the disease is central nervous system cancer.